Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
57
OPGN Quote, Financials, Valuation and Earnings
Last price:
$24.5000
Seasonality move
:
32.23%
Day range:
$18.0000 - $24.5000
52-week range:
$0.0000 - $34.0000
Dividend yield:
0%
P/E ratio:
61.27x
P/S ratio:
27.50x
P/B ratio:
24.29x
Volume:
1.1K
Avg. volume:
6.4K
1-year change:
2272.88%
Market cap:
$246.7M
Revenue:
$5.2M
EPS (TTM):
$0.40
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-- | -- | -- | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18.5M | -$0.03 | -56.37% | -70.93% | $1.55 |
|
LNSR
LENSAR, Inc.
|
$20.5M | -$0.09 | 30.98% | -90.51% | $15.00 |
|
LUDG
Ludwig Enterprises, Inc.
|
-- | -- | -- | -- | -- |
|
USAQ
QHSLab, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
$24.5000 | -- | $246.7M | 61.27x | $0.00 | 0% | 27.50x |
|
LAB
Standard BioTools, Inc.
|
$1.17 | $1.55 | $449.9M | -- | $0.00 | 0% | 4.22x |
|
LNSR
LENSAR, Inc.
|
$11.86 | $15.00 | $141.7M | -- | $0.00 | 0% | 2.38x |
|
LUDG
Ludwig Enterprises, Inc.
|
$0.0221 | -- | $3.6M | -- | $0.00 | 0% | 37,130.15x |
|
USAQ
QHSLab, Inc.
|
$0.7000 | -- | $7.9M | -- | $0.00 | 0% | 3.52x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
16.9% | -36,920.421 | 205167.16% | 5.70x |
|
LAB
Standard BioTools, Inc.
|
6.77% | 0.841 | 6.26% | 1.86x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.239 | 1.79% | 0.65x |
|
LUDG
Ludwig Enterprises, Inc.
|
-144.65% | -0.654 | 24.05% | 0.00x |
|
USAQ
QHSLab, Inc.
|
162.97% | -1.888 | 73.75% | 0.17x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-$48.1K | -$702.2K | 70.06% | 89.47% | -5625.96% | -$333.3K |
|
LAB
Standard BioTools, Inc.
|
$10.2M | -$21.9M | -13.22% | -14.14% | -92.14% | -$1.7M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
LUDG
Ludwig Enterprises, Inc.
|
-- | -$371.4K | -- | -- | -419868.12% | -$139.1K |
|
USAQ
QHSLab, Inc.
|
$475.6K | $96.3K | -35.74% | -- | 13.05% | $2.6K |
OpGen, Inc. vs. Competitors
-
Which has Higher Returns OPGN or LAB?
Standard BioTools, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of 58.42%. OpGen, Inc.'s return on equity of 89.47% beat Standard BioTools, Inc.'s return on equity of -14.14%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LABStandard BioTools, Inc.43.03% $0.05 $455.1M -
What do Analysts Say About OPGN or LAB?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 22.45%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 32.48%. Given that Standard BioTools, Inc. has higher upside potential than OpGen, Inc., analysts believe Standard BioTools, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is OPGN or LAB More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.967%.
-
Which is a Better Dividend Stock OPGN or LAB?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LAB?
OpGen, Inc. quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $23.8M. OpGen, Inc.'s net income of -$608.7K is lower than Standard BioTools, Inc.'s net income of $13.9M. Notably, OpGen, Inc.'s price-to-earnings ratio is 61.27x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 27.50x versus 4.22x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.27.50x 61.27x -- -$608.7K LABStandard BioTools, Inc.4.22x -- $23.8M $13.9M
-
Which has Higher Returns OPGN or LNSR?
LENSAR, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -25.94%. OpGen, Inc.'s return on equity of 89.47% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About OPGN or LNSR?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 22.45%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 26.48%. Given that LENSAR, Inc. has higher upside potential than OpGen, Inc., analysts believe LENSAR, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LNSRLENSAR, Inc.0 2 0 -
Is OPGN or LNSR More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.687, suggesting its less volatile than the S&P 500 by 31.253%.
-
Which is a Better Dividend Stock OPGN or LNSR?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LNSR?
OpGen, Inc. quarterly revenues are --, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. OpGen, Inc.'s net income of -$608.7K is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, OpGen, Inc.'s price-to-earnings ratio is 61.27x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 27.50x versus 2.38x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.27.50x 61.27x -- -$608.7K LNSRLENSAR, Inc.2.38x -- $14.3M -$3.7M
-
Which has Higher Returns OPGN or LUDG?
Ludwig Enterprises, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -427991.3%. OpGen, Inc.'s return on equity of 89.47% beat Ludwig Enterprises, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LUDGLudwig Enterprises, Inc.-- -- -$1.4M -
What do Analysts Say About OPGN or LUDG?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 22.45%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that OpGen, Inc. has higher upside potential than Ludwig Enterprises, Inc., analysts believe OpGen, Inc. is more attractive than Ludwig Enterprises, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LUDGLudwig Enterprises, Inc.0 0 0 -
Is OPGN or LUDG More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.470, suggesting its more volatile than the S&P 500 by 146.979%.
-
Which is a Better Dividend Stock OPGN or LUDG?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LUDG?
OpGen, Inc. quarterly revenues are --, which are smaller than Ludwig Enterprises, Inc. quarterly revenues of --. OpGen, Inc.'s net income of -$608.7K is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, OpGen, Inc.'s price-to-earnings ratio is 61.27x while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 27.50x versus 37,130.15x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.27.50x 61.27x -- -$608.7K LUDGLudwig Enterprises, Inc.37,130.15x -- -- $31.3K
-
Which has Higher Returns OPGN or USAQ?
QHSLab, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of 4.53%. OpGen, Inc.'s return on equity of 89.47% beat QHSLab, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M USAQQHSLab, Inc.64.52% $0.00 $970.2K -
What do Analysts Say About OPGN or USAQ?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 22.45%. On the other hand QHSLab, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that OpGen, Inc. has higher upside potential than QHSLab, Inc., analysts believe OpGen, Inc. is more attractive than QHSLab, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 USAQQHSLab, Inc.0 0 0 -
Is OPGN or USAQ More Risky?
OpGen, Inc. has a beta of -3,423.037, which suggesting that the stock is 342403.692% less volatile than S&P 500. In comparison QHSLab, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 48.993%.
-
Which is a Better Dividend Stock OPGN or USAQ?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QHSLab, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. QHSLab, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or USAQ?
OpGen, Inc. quarterly revenues are --, which are smaller than QHSLab, Inc. quarterly revenues of $737.1K. OpGen, Inc.'s net income of -$608.7K is lower than QHSLab, Inc.'s net income of $33.4K. Notably, OpGen, Inc.'s price-to-earnings ratio is 61.27x while QHSLab, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 27.50x versus 3.52x for QHSLab, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.27.50x 61.27x -- -$608.7K USAQQHSLab, Inc.3.52x -- $737.1K $33.4K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
